News & Updates
Filter by Specialty:
COVID-19 associated with increased BPH complications and deterioration
SARS-CoV-2 infection is associated with significantly higher incidence of benign prostatic hyperplasia (BPH) complications and addition of 5-alpha reductase inhibitor (5ARI) for combination therapy in male patients with lower urinary tract symptoms (LUTS) on alpha-1 adrenoreceptor blocker (AARB) monotherapy, a territory-wide retrospective cohort study in Hong Kong has shown.
COVID-19 associated with increased BPH complications and deterioration
14 Feb 2024Does radiotherapy improve survival in NSCLC patients with cachexia?
Palliative-intent radiation was performed more frequently in patients with advanced nonsmall-cell lung cancer (NSCLC) and cachexia than those without weight loss. Unfortunately, tumour-directed therapy, whether in a curative or a palliative approach, proves inadequate in improving cachexia patient survival across all stages of the disease.
Does radiotherapy improve survival in NSCLC patients with cachexia?
06 Feb 2024Sitra + nivo slightly better than docetaxel in advanced NSCLC
Treatment with sitravatinib plus nivolumab (sitra + nivo) results in numerically longer median overall survival (OS), albeit statistically nonsignificant, in patients with advanced nonsquamous nonsmall-cell lung cancer (NSCLC) compared with docetaxel, a study has shown.